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In Brief
The role of skin commensal microbes in dermal cellular responses is largely unknown. Gimblet et al. investigate the role of the skin microbiota during cutaneous leishmaniasis. Leishmania infection creates a dysbiotic skin microbiota that is transmissible to naive skin. Additionally, dysbiosis prior to infection or injury exacerbates skin inflammation.
INTRODUCTION
The skin is a barrier and the body's first line of defense against injury and infection. It also hosts commensal populations of bacteria, fungi, and viruses that may influence wound healing, the immune response to infection, and inflammatory responses that occur in chronic diseases (Canesso et al., 2014; Grice et al., 2010; Naik et al., 2012) . Though there are strong associations between certain human diseases and changes in the skin microbiota (Kong et al., 2012; Loesche et al., 2017; Oh et al., 2013) , the consequences of such changes are unclear, including the role of skin commensal microbes in modulating dermal cellular responses. Animal models in which microbial communities can be manipulated are essential to determine whether these changes influence the outcome of disease.
Cutaneous leishmaniasis is caused by intracellular protozoan parasites and is characterized by a spectrum of clinical manifestations, ranging from self-healing single lesions to chronic, and in some cases metastatic, lesions (Scott and Novais, 2016) . The factors responsible for chronic disease in leishmaniasis are still being defined, although it is clear that some of the most severe forms of the disease are not caused by uncontrolled parasite replication, but rather an exaggerated immune response leading to excessive inflammation (Antonelli et al., 2005; Lopez Kostka et al., 2009; Santos et al., 2013; Gonzalez-Lombana et al., 2013; Novais et al., 2013; Crosby et al., 2014) . Unfortunately, there is no vaccine for leishmaniasis and drug treatment is often ineffective, which provides the impetus for better understanding the factors that drive the destructive inflammatory responses. Some of these severe forms of disease can be mimicked in mice, which can develop healing or non-healing disease following L. major infection depending upon whether a dominant Th1 or Th2 response develops (Scott and Novais, 2016) . Less well understood is the role the skin microbiota plays in cutaneous leishmaniasis. Although it has been reported that the course of infection in germ-free mice differs from conventional mice (de Oliveira et al., 1999; Naik et al., 2012; Oliveira et al., 2005) , how the skin microbiota changes in patients and conventional mice, and whether such changes influence disease, is less clear.
In this study, we found that infection with leishmania parasites causes a decrease in bacterial diversity in the skin that is characterized by communities dominated by Staphylococcus spp. and/ or Streptococcus spp in both humans and mice. We hypothesized that disease-associated shifts in the skin microbiota (''dysbiosis'') contribute to lesion pathology and dermal cellular responses, including immune and inflammatory responses in L. major infection. To test this, we utilized a mouse model of cutaneous leishmaniasis and found that infection with L. major changed the skin microbiota in a manner dependent on disease severity. Leishmania-induced dysbiosis was not confined to the site of infection, but occurred globally on the skin of infected mice and, moreover, was transferred to uninfected co-housed mice. Colonization of skin with Staphylococcus xylosus isolated from the dysbiotic mice increased inflammatory responses in a contact hypersensitivity model, although not in normal skin, indicating that dysbiosis might exacerbate disease. Dysbiotic microbiota, when transferred to naive mice prior to leishmania infection, increased disease pathology compared to control animals. Taken together, these results indicate that the skin microbiota influences the inflammatory response in leishmaniasis and other inflammatory skin conditions. This work has significant implications for the treatment of cutaneous leishmaniasis and other skin diseases, and highlights the potential of the skin microbiota as a therapeutic target. (A) Swabs were collected from the lesion, nearby adjacent skin, and contralateral skin sites for 16S rRNA analysis. (B) Bacterial diversity was assessed by the number of observed species-level OTUs and Shannon index. Upper and lower box hinges correspond to first and third quartiles, and the distance between these quartiles is defined as the interquartile range (IQR). Lines within the box depict median, and whiskers extend to the highest and lowest values within 1.5 times the IQR. Outliers of the IQR are depicted as dots above or below the whiskers. (C) Bar charts represent intragroup mean BrayCurtis dissimilarity between each skin site. Data are presented as mean ± SEM. (D) PCoA values for weighted UniFrac analysis were plotted and colored based on the Dirichlet multinomial cluster assignment. (E) Stacked bar charts represent the proportion of the top ten taxa present in each Dirichlet cluster. Swabs were collected from n = 44 patients. **p < 0.01; ***p < 0.001; ****p < 0.0001. See also Figure S1 and Tables S1 and S2.
RESULTS

Characterization of Microbiota Colonizing Human Leishmaniasis Lesions and Skin
Dysbiosis in skin microbiota is often associated with inflammation and disease (Grice et al., 2010; Kobayashi et al., 2015; Kong et al., 2012; Oh et al., 2013) , suggesting that cutaneous lesions in leishmaniasis might also exhibit changes in the skin-residing bacterial communities. To test this, we analyzed the microbiota of 44 patients infected with L. braziliensis (72.7% male, 27.3% female; median age, 27 years old), with lesions present at various body sites (Table S1 ). We collected two to three skin swabs for each patient, including the lesion, adjacent skin near the lesion, and unaffected contralateral skin of the same body site as the lesion ( Figure 1A ). Taxonomic composition of unaffected contralateral skin fell within the normal range of what has been previously observed of the healthy skin microbiome, and colonizing microbiota was assessed with respect to gender and no significant differences were found (Meisel et al., 2016;  Figure S1A ). Bacterial diversity was significantly lower in lesions compared to unaffected contralateral skin and adjacent skin sites, as measured by the observed species-level operational taxonomic units (OTUs) and Shannon diversity indices ( Figure 1B) .
Interestingly, the skin microbiota on the adjacent skin sites appeared more similar in composition to the lesions than to the contralateral skin ( Figure S1A ). To quantify the similarity between each site where specimens were collected, we used the Bray-Curtis dissimilarity metric of shared microbial community structure.
We observed that lesion and adjacent skin shared greater microbial community structure compared to contralateral and adjacent skin ( Figure 1C ). These data suggest that microbiota colonizing the lesion is shared with adjacent skin sites, which may have implications in the immune responses at those sites.
We then applied a Dirichlet multinomial mixture model-based approach to assign the lesions to different community types (CTs) based on their taxonomic composition. Lesions clustered into three CTs (Figures 1D and S1B) with distinct bacterial compositions. The top discriminating taxa in CT1 was Staphylococcus aureus, CT2 displayed a heterogeneous composition with no dominating taxa, and CT3 was dominated by an unclassified species of Streptococcus ( Figure 1E ; Table S2 ). These results suggest that cutaneous leishmaniasis lesions are colonized with microbiota similar to other cutaneous ulcers (Kong et al., 2012; Oh et al., 2013; Loesche et al., 2017) , but display less heterogeneity of the colonizing microbiota, which is driven primarily by proportions of Staphylococcus aureus and Streptococcus spp. in this cohort. Interestingly, neither bacteria were associated with larger lesion sizes ( Figure S1C ), but lesion size may not be a good predictor of disease severity or outcome. Additional epidemiologic studies may be needed to further evaluate the influence of the skin microbiota in cutaneous leishmaniasis, yet these results clearly demonstrate that infection with leishmania alters the skin microbiota, creating several types of dysbiosis.
L. major Infection Induces Changes to the Skin Microbiota in Mouse Models
Since the influence on disease of a dysbiosis is difficult to evaluate in humans, we employed a mouse model of leishmaniasis to assess the role dysbiosis might play in cutaneous leishmaniasis. C57BL/6 mice were infected in the ear with L. major parasites, which led to the development of a lesion that resolved by 12 weeks post-infection (Figures 2A and 2B ). Prior to infection, and at 6 and 12 weeks post-infection, swabs were collected from the ventral and dorsal ear skin and sequencing of the 16S ribosomal RNA gene was employed to assess skin microbial diversity and composition. Alpha diversity, as measured by the number of observed species-level OTUs and Shannon diversity indices, decreased at 6 weeks post-infection, but returned to pre-infection levels upon lesion resolution ( Figures 2C and 2D ). This shift in alpha diversity was paralleled by a significant increase in the relative abundance of Staphylococcus spp. after lesion development that returned to pre-infection levels once Figure 1B . (E and F) Stacked bar charts represent the proportion of the top ten taxa present (E) from ear swabs and (F) from fecal pellets at 0, 6, and 12 weeks post-infection. Each column represents the proportion of taxa for an individual mouse. Data represent two independent experiments (n = 1 skin swab each from 15 mice and n = 1 fecal pellet each from 10 mice). *p < 0.05; ***p < 0.001.
the lesions resolved ( Figure 2E ). Speciation of the Staphylococcus species associated with L. major infection was performed by biochemical typing in an automated system (Microscan, Beckman Coulter) and isolates were identified as S. xylosus, a common commensal bacteria found on mouse skin (Nagase et al., 2002) . Isolates were then confirmed as S. xylosus by MALDI-TOF mass spectrometry using the Bruker MALDI Biotyper System (Beckman Coulter). The MALDI-TOF identification score for all isolates tested was >2.299, which indicates a secure genus identification and a highly probable species identification. Since infections can often lead to changes in the intestinal microbiota (Kamdar et al., 2016; Lozupone et al., 2013) , we also analyzed the fecal microbiota of infected mice, but found no significant changes in the fecal bacterial populations throughout the course of infection with L. major ( Figure 2F ), demonstrating that dysbiosis caused by infection is localized to the skin.
L. major-Induced Dysbiosis Differs
Depending on the Severity of the Disease Inflammatory responses induced by a variety of skin insults lead to changes in the skin microbiota (Grice et al., 2010; Gontcharova et al., 2010; Kong et al., 2012; Oh et al., 2013; Loesche et al., 2017) , but whether the magnitude of the insult alters the nature or degree of the dysbiosis is not known. To address this, we compared the microbiota from L. major-infected C57BL/6 mice that resolve their infection and BALB/c mice that develop severely ulcerated non-healing lesions (Figures 3A and 3B) (Scott and Novais, 2016) . Similar to C57BL/6 mice, BALB/c mice had significantly lower alpha diversity at 6 weeks post-infection ( Figure 3C ). However, in contrast to the dominance of Staphylococcus spp. found on lesions of C57BL/6 mice, BALB/c mice had a dominance of Streptococcus spp. at 6 weeks post-infection, ( Figure 3D ). To rule out the possibility that the increase in Streptococcus in nonhealing BALB/c mice was due to differences in the mouse strain, we depleted IL-12 in C57BL/6 mice, which leads to non-healing lesions similar to those seen in BALB/c mice (Heinzel et al., 1989 ; Scharton-Kersten et al., 1995). As expected, anti-IL-12 mAb-treated mice developed large non-healing lesions ( Figures  3E and 3F ). We first analyzed the skin microbiota of naive mice treated with anti-IL-12 prior to infection and found that treatment does not significantly alter the proportions of Staphylococcus spp. or Streptococcus spp. ( Figure S2A ). However, after 2 weeks of L. major infection, Staphylococcus spp. made up a high proportion of the skin microbiota in the anti-IL-12-treated mice, while remaining low in the isotype-treated mice until 4 weeks post-infection ( Figures 3G and S2B ). At 6 weeks post-infection, the relative abundance of Streptococcus spp. remained less than 1% of the total population in control mice, but it increased significantly in anti-IL-12-treated mice to >50% relative abundance (Figures 3G and S2B) , further demonstrating that Streptococcus spp. are associated with more severely ulcerated lesions. Taken together, our data suggest that L. major infection elicits severity-dependent changes in the skin microbiota.
S. xylosus-Mediated Inflammation Is Dependent on Tissue Damage
To determine if the dysbiosis caused by L. major infection would influence skin inflammatory responses, we topically associated naive mice with S. xylosus ( Figure 4A ). One week following colonization with S. xylosus, mice exhibited a significantly higher relative and absolute abundance of Staphylococcus spp. compared with naive mice by culture-independent ( Figure 4B ) and culturedependent assays ( Figure 4C ). Interestingly, S. xylosus colonization did not influence ear thickness ( Figure 4D) ; the frequency or total cell numbers of CD4+ T cells, CD8+ T cells, and CD11b+ myeloid cells; IL-1b production; Ly6G+ neutrophils (Figures 4E and S3A-S3E); or T cell cytokine production (Figures S3F and S3G) . To determine if S. xylosus incites inflammation upon breach of the skin barrier, we injected mice intradermally with S. xylosus and analyzed the inflammatory response in the skin. These mice had significantly higher expression of Il17, Tnfa, Il1b, Cxcl1, and Ccl2 compared with either naive or colonized mice ( Figures 4F and 4G) , suggesting that S. xylosus might contribute to skin inflammation when the skin barrier is compromised.
While skin colonized with S. xylosus appeared immunologically normal, based on the results above we hypothesized that the response to damage might differ between normal and dysbiotic skin. We tested this idea using a model of contact (C) Ear lysates from naive and S. xylosus colonized mice were cultured on mannitol salt agar plates and colony-forming units (CFUs) were counted after overnight incubation at 37 C.
(D) Ear thickness was assessed in naive and colonized mice. (E) Flow cytometry analysis was performed for the frequency of CD4+; CD8+; and CD11b+, IL-1b+, and Ly6G+ cells in the ears of naive or colonized mice 14 days post-association. Cells were pregated on live, singlet CD45+ cells. Data are representative of two independent experiments (n = 1 ear tissue each from 4 mice in each group). C57BL/6 mice were topically colonized or intradermally infected in the ear with S. xylosus. (F and G) Fourteen days later, skin was harvested and mRNA expression was assessed for (F) cytokine and (G) chemokine genes. Data are representative of one experiment (n = 1 ear tissue each from 5 mice in each group). ns, not significant; *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001. In (B)-(G), data are presented as mean ± SEM. See also Figure S3 .
hypersensitivity in which sensitizing and challenging the skin with a known skin irritant, dinitrofluorobenzene (DNFB), increases transepidermal water loss, an indication of skin barrier dysfunction and inflammation ( Figure 5A ). Naive C57BL/6 mice were colonized with S. xylosus prior to sensitization with DNFB (Figure 5B) . DNFB challenge resulted in a significant increase in neutrophils (CD11b+ Ly6G+) and expression of pro-IL-1b from myeloid cells ( Figures 5C and 5D) . A similar immune response was observed when mice were colonized with S. xylosus during the challenge phase of DNFB treatment ( Figure S4A ). Since IL-17 and IL-1 can both lead to an increase in neutrophil recruitment, we investigated whether these cytokines played a role in the increase of neutrophils in S. xylosus-treated mice. Mice colonized with S. xylosus were treated with an isotype control mAb, anti-IL-17A mAb, or anti-IL-1R mAb prior to DNFB challenge ( Figure 5E ), and neutralizing IL-17 or IL-1 decreased neutrophil recruitment ( Figure 5F ). Thus, it appears that a commensal such as S. xylosus can induce IL-17 and IL-1 expression in conditions of tissue stress and damage, leading to increased inflammation.
To determine if colonization with Streptococcus spp. might have a similar effect, we isolated Streptococcus from L. major- infected mice that had been treated with anti-IL-12 mAb. The immune responses in mice sensitized and challenged with DNFB colonized with Streptococcus were unchanged ( Figure S4B ). However, we were unable to achieve stable colonization with the streptococcal isolate (Figure S4C ), suggesting that this particular lesion-associated Streptococcus isolate requires additional, as-yet-undefined nutrients or other conditions to colonize normal skin. We hypothesized that the Streptococcus isolate would establish a better colonization on lesional skin; thus, we infected mice with L. major, allowed the lesion to develop, and then colonized with the Streptococcus isolate. Indeed, Streptococcus colonized the lesion better than naive skin ( Figure S4D ). Interestingly, colonization with the Streptococcus isolate did not exacerbate lesion development or the inflammatory response in the skin (Figures S4E and S4F ).
L. major-Induced Dysbiosis Is Transmissible to Uninfected Skin
The observation that the lesional microbiota of human cutaneous leishmaniasis extends to adjacent, seemingly normal skin sites prompted us to ask if the same was true in the mouse model of L. major infection. To answer this question, we compared the bacterial composition at the lesion site (infected ear) and the contralateral ear of infected mice. As expected, the infected ear was dominated by Staphylococcus spp. at the peak of infection. Interestingly, the contralateral ear also had a high proportion of Staphylococcus spp., despite the absence of infection ( Figure 6A ). We also observed higher bacterial loads on the infected and contralateral ears when compared to naive skin ( Figure 6B ). These data demonstrate that in the mouse model, the dysbiotic microbiota caused by L. major infection is transmissible to the non-inflamed, contralateral ear.
A dysbiotic intestinal microbiota is often transmissible by simply co-housing mice (Elinav et al., 2011; Zenewicz et al., 2013) . Whether transmission of the skin microbiota also occurs is less clear, although co-habiting families may share their skin microbiota (Song et al., 2013) . To directly address this issue, we tested if naive mice co-housed with L. major-infected mice might acquire their dysbiotic microbiota. C57BL/6 mice were infected with L. major and co-housed with naive mice for 6 weeks, while a group of control naive mice were housed separately. Similar to the infected and contralateral ears, the skin of the co-housed naive mice also acquired a high abundance of Staphylococcus spp., while the control naive mice maintained a diverse population of bacteria ( Figure 6C) . Similar to what we observed with (B) Swabs from naive or L. major-infected C57BL/6 mice were cultured on mannitol salt agar plates and CFUs were counted to determine bacteria burden. Data are representative of one experiment (for naive group, n = 1 swab from the ear of 10 mice; for infected and contralateral ears, n = 1 swab of each ear from 12 mice). (C) Naive C57BL/6 mice were co-housed with L. major-infected mice for 6 weeks, while control naive mice were housed separately. Swabs were collected from co-housed naive and control naive mice. Stacked bar charts represent the proportion of taxa present in each sample. Data are representative of two independent experiments (for infected group, n = 1 swab of each ear from 15 mice; for co-housed naive, n = 1 swab of one ear from 10 mice; for control naive, n = 1 swab of one ear from 5 mice). (D) Bar graphs depict ear thickness of control and co-housed naive mice. (E) Cells were isolated from the ears of co-housed naive mice and control naive mice to assess for CD4+; CD8+; and CD11b+, IL-1b+, and Ly6G+ cells by flow cytometry. Data are representative of one experiment (co-housed naive, n = 1 ear tissue each from 4 mice; control naive, n = 1 ear tissue each from 5 mice). ns, not significant; **p < 0.01; ***p < 0.001. In (B), (D), and (E), data are presented as mean ± SEM. See also Figure S5 .
S. xylosus colonized mice, the ear thickness and immune response in co-housed naive mice were not altered by dysbiosis ( Figures 6D, 6E, and S5 ). Our data demonstrate that the dysbiotic skin microbiota caused by L. major infection is transmissible to naive mice without causing inflammation. This model allows us to assess the consequences of dysbiosis in inflammatory responses occurring in the skin.
L. major-Induced Dysbiosis Exacerbates Disease during Inflammation and Infection
While we and others have shown that colonizing mice with a single organism at high levels can alter immune responses (Figure 5 ) (Naik et al., 2012 (Naik et al., , 2015 , whether a naturally transmitted dysbiosis would alter skin immune responses has not been tested. To assess this, we co-housed naive mice with L. major-infected mice for 6 weeks to create naive dysbiotic mice. Control mice were housed separately and never exposed to L. major-infected mice. We then compared the contact hypersensitivity responses of both groups of mice to DNFB. Dysbiotic co-housed mice had significantly more neutrophils and pro-IL-1b production in the skin than control mice ( Figures 7A  and 7B ), similar to mice colonized with high numbers of bacteria. Taken together, our results suggested that mice with dysbiotic skin might respond differently to infection with L. major when compared with normal mice. To determine if this was the case, naive mice were co-housed with L. major-infected mice for 6 weeks and then infected with L. major. At 5 weeks post-infection, we analyzed the inflammatory cells and cytokines in the lesions of control and dysbiotic mice. Similar to DNFB challenge, L. major-infected skin had significantly more neutrophils and IL-1b in dysbiotic mice compared to control mice ( Figures 7C  and 7D) . Furthermore, the dysbiotic mice had significantly greater lesion severity, characterized by increased skin ulceration, than control mice ( Figures 7E and 7F) , despite similar parasite burdens ( Figure 7G ). These findings demonstrate that the skin microbiota influences the magnitude of lesion severity following infection with L. major. (G) Parasite burdens were assessed using a limiting dilution assay after 5 weeks post-infection. Data are representative of two independent experiments (for dysbiotic group, n = 1 ear tissue each from 4 mice; for control group, n = 1 ear tissue each from 5 mice). ns, not significant; *p < 0.05; **p < 0.01; ***p < 0.001. Data are presented as mean ± SEM.
DISCUSSION
Interactions between the immune system and the microbiota can be either beneficial or harmful, depending on the context (Gaboriau-Routhiau et al., 2009; Naik et al., 2012 Naik et al., , 2015 Atarashi et al., 2013; Kobayashi et al., 2015) . In our studies, we found that leishmania infections in humans and mice change the composition of the skin microbiota. The nature of the changes in mice differed depending on the severity of inflammation, with Staphylococcus spp. dominant in moderate lesions and Streptococcus spp. increasing in more severe lesions in mice infected with L. major. In humans, we found individuals with a dominance of Staphylococcus aureus, Streptococcus spp., or a mixture of both, although whether these distinct skin microbiota influence the outcome of disease is yet unknown. However, our studies in mice clearly suggest that further studies in patients are warranted.
Why dysbiosis occurs during cutaneous leishmaniasis, or in other inflammatory conditions, is unknown. Innate defenses, such as antimicrobial peptides (AMPs), can target certain bacteria and play a role in disrupting the microbiota in the intestine and in the skin (Cogen et al., 2010; Dorschner et al., 2001; Natsuga et al., 2016; Nizet et al., 2001; Salzman et al., 2010) , and may also in part contribute to the dysbiosis caused by L. major infection. We found that infection with L. major causes changes in AMP expression in the skin ( Figure S6 ), and mice deficient in a cathelicidin-type antimicrobial peptide (CAMP) appear more susceptible to infection with L. amazonensis (Kulkarni et al., 2006) . Whether this deficiency in CAMP causes changes in the skin microbiota remains to be determined, but these results, in addition to our own findings, suggest that AMPs in cutaneous leishmaniasis warrant further investigation. How AMPs might promote these changes is unclear, but virulence factors can make bacteria resistant to AMPs, and both Staphylococcus spp. and Streptococcus spp. express genes that protect them from AMP killing (Kristian et al., 2005; Peschel et al., 1999 Peschel et al., , 2001 , potentially providing them with a survival advantage during L. major infection.
One difficulty in studying the microbiota is assessing how changes in the skin microbiota influence disease, since skin dysbiosis is the consequence of the inflammatory response in the skin. While transmissibility of dysbiotic microbiota has been demonstrated in the intestinal tract (Elinav et al., 2011; Zenewicz et al., 2013) , our data demonstrate transmissibility of the skin microbiota in a murine model. In this study and previous studies, colonization with a single bacterial species enhanced skin inflammation (Naik et al., 2012) . In our studies, enhanced inflammation was only observed when there was pre-existing tissue damage and inflammation. The differences between these studies are likely due to differences in bacterial species. Although mono-colonization will be essential for dissecting how particular bacteria alter immune responses, it will not replicate the complex changes that might be associated with a naturally occurring dysbiosis. Our ability to generate a mouse with dysbiotic skin microbiota overcomes this issue, and has allowed us to demonstrate that a naturally acquired dysbiosis promotes increased inflammatory responses and, in the case of cutaneous leishmaniasis, increased disease. It is not clear how this transmission occurs, although consistent with our results, evidence from human studies indicates that the environment influences the skin microbiota (Song et al., 2013) , and L. major infections in mice may provide a model to study the mechanisms involved.
The findings from our mouse model of cutaneous leishmaniasis are similar to the dysbiosis that occurs during human cutaneous leishmaniasis. Interestingly, the different topological sites of our samples did not show any differences in the skin microbiota, although we only had a few samples from moist and sebaceous sites. Yet comparable to what has been reported by culture-dependent and culture-independent methods (Isaac-Má rquez and Lezama-Dá vila, 2003; Sadeghian et al., 2011; Layegh et al., 2015; Salgado et al., 2016) , our results demonstrated that Staphylococcus aureus and an unclassified species of Streptococcus are highly abundant on lesional skin. This dysbiosis was also present on skin sites adjacent to the lesion. However, unlike our mouse model, the dysbiotic skin microbiota did not appear to be transmissible to contralateral skin sites. It is not yet clear why the dysbiosis is confined to the lesional and adjacent skin sites in human cutaneous leishmaniasis, but it is likely to be due to differences in grooming and environmental conditions between mice and humans. However, the similarities in the dysbiotic microbiota between the mouse model and human cutaneous leishmaniasis demonstrate the utility of our model system to study the role of skin microbiota during leishmania infections.
One of our findings was that skin dysbiosis does not cause immunologic changes in the skin or disease by itself, nor did topical colonization with S. xylosus. However, in mice where tissue stress is induced by contact hypersensitivity to DNFB, S. xylosus exacerbated the inflammatory response, assessed by increased recruitment of neutrophils and upregulated expression of IL-1b. These results are consistent with other studies showing that mice with barrier defects allow Staphylococcus to penetrate the epidermal barrier and subsequently increase cytokine expression in the skin (Nakatsuji et al., 2016) . In some situations, the cytokine production may be protective, such as during a fungal infection (Naik et al., 2015) . However, in cutaneous leishmaniasis, neutrophils and IL-1b are associated with increased pathology rather than the restriction of parasites (Charmoy et al., 2016; Ferná ndez-Figueroa et al., 2012; Gimblet et al., 2015; Gonzalez-Lombana et al., 2013; Novais et al., 2015; Voronov et al., 2010) . Thus, we hypothesize that L. major infection disturbs skin barrier integrity while simultaneously inducing a dysbiosis in the skin microbiota, which taken together lead to the increased recruitment of neutrophils and IL-1b recruiting cells to the skin, and cause increased lesion severity.
These results raise the obvious question of what role systemic or topical antibiotics might play in moderating inflammatory responses associated with leishmaniasis (Grice, 2014) . As previous studies with germ-free mice indicate that commensal bacteria may contribute to lesion severity in cutaneous leishmaniasis (de Oliveira et al., 1999; Naik et al., 2012; Oliveira et al., 2005) , and our studies demonstrate that dysbiosis exacerbates disease, it is reasonable to predict that antibiotic treatment might be beneficial in leishmaniaisis. While we have been unsuccessful in moderating disease in mice by antibiotic treatment, there are examples of antibiotic therapy being protective in some cutaneous leishmaniasis patients (Aguiar et al., 2010; Ben Salah et al., 2013; Kim et al., 2009; Krolewiecki et al., 2002) . However, there are other studies that find no effect of antibiotic treatment (Iraji and Sadeghinia, 2005; Neva et al., 1997) , and moreover, when such treatment shows a positive outcome the mechanism involved is not clear. Given the different outcomes of studies looking at antibiotic treatment, and taken together with our results, it appears that the role of antibiotics in treatment needs further investigation.
In summary, our findings indicate that the skin microbiota not only changes during leishmania infection, but also when transmitted to naive mice can enhance disease to leishmania. These findings have obvious consequences when considering how to limit disease severity in cutaneous leishmaniasis. Moreover, since we find that the dominant bacteria associated with a leishmania-induced dysbiosis differ depending upon the severity of disease in mice, further epidemiologic studies with patients to determine the consequences of differing types of dysbiosis are warranted. Finally, we found that dysbiotic skin microbiota can be transmitted to conventional naive mice, which provides a model to define how and when dysbiosis might influence control of other infections, autoimmune diseases, and wound healing.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 9 CFUs of bacteria were applied to the entire mouse body using sterile cotton swabs, every other day for a total of 4 times. For intradermal infections, mice were inoculated with 10 mL of 10 8 -10 9 CFU bacteria/mL culture. For CFU quantification, the dermal sheets of the mouse ears were homogenized in 1mL of PBS using a tissue homogenizer (FastPrep-24, MP Biomedical) and plated on tryptic soy blood agar (Remel) or mannitol salt agar (Acumedia) in serial dilutions. Plates were incubated overnight at 37 C and CFUs were counted the next day.
Contact Hypersensitivity and Antibody Treatments
For sensitization, 1-fluoro-2,4-dinitrobenzene (DNFB) (Sigma-Aldrich) was added to a 3:1 acetone:olive oil dissolvent to get a final concentration of 0.5%. Mice were treated on the belly with 30 mL of the mixture. During the challenge phase, mice were treated with 20 mL of 0.3% DNFB (in 3:1 acetone:olive oil) on the ear once a day, for a total of 3 days. The mice were euthanized 24 hr after the last challenge. In some experiments, mice were treated with 500 mg of a Rat IgG2a isotype monoclonal antibody (BioXcell, clone 2A3, RRID: AB_1107769), an anti-mouse IL-17A monoclonal antibody (BioXcell, clone 17F3, RRID: AB_10950102), or an anti-mouse IL-1R monoclonal antibody (BioXcell, clone JAMA-147, RRID: AB_2661843), one day prior and one day after the first challenge with DNFB.
Preparation of Dermal Sheets
The dorsal and ventral sides of the mouse ear were split mechanically and placed dermis side down in a 24 wells plate in RPMI 1640 containing 0.25 mg/mL of Liberase TL (Roche, Diagnostics Corp.) and 10 mg/mL DNase I (Sigma-Aldrich). Ears were incubated for 90 min at 37 C in a 24-well plate. Dermal cell suspensions were prepared by dissociation on 40 mm cell strainer (Falcon) in PBS containing 0.05% BSA and 20 mM EDTA.
Antibodies and Flow Cytometry
Single cell suspensions from the ear were obtained as described above. For analysis of surface markers and intracellular cytokines, some cells were incubated for 4 hr with 10 mg/mL of brefeldin A, 50 ng/mL of PMA and 500 ng/mL ionomycin (Sigma-Aldrich). RNA Isolation, Purification, and Quantitative Real-Time PCR Total RNA was extracted from ear tissue samples in 500 mL of RLT lysis buffer (QIAGEN). The sample was homogenized using a tissue homogenizer (FastPrep-24, MP Biomedical), and total RNA was extracted according to the recommendations of the manufacturer and further purified using the RNeasy Mini kit (QIAGEN). RNA was reverse transcribed using high capacity RNA-to-cDNA Kit (Applied Biosystems). Real-time RT-PCR was performed on a ViiA 7 Real-Time PCR System (Applied Biosystems). Relative quantities of mRNA for several genes were determined using SYBR Green PCR Master Mix (Applied Biosystems) and by the comparative threshold cycle method, as described by the manufacturer. mRNA levels for each sample were normalized to the ribosomal protein S11 gene (RPS11). The primer sequences are reported in Table S3 .
Microbiota Collection, Sequencing, and Analysis Microbiota samples were collected from the ear of mice using a swab (Catch-all Sample Collection Swab, Epicenter) moistened in Yeast Cell Lysis Buffer (from MasterPure Yeast DNA Purification Kit; Epicenter). DNA was isolated from swab specimens using the PureLink Genomic DNA Mini Kit (Invitrogen) and amplification of the 16S-V4 region for the murine samples, and 16S-V1-V3 region for the human samples, was performed as previously described (Hannigan et al., 2014; Meisel et al., 2016) . Sequencing of 16S rRNA amplicons was performed at the Penn Next Generation Sequencing Core using the Illumina MiSeq platform with 150 bp pairedend 'V4' chemistry for murine samples and with 300 bp paired-end 'V1-V3 0 chemistry for the human samples. For the fecal samples, DNA was isolated using the PowerSoil DNA Isolation Kit (Mo Bio) and sequencing of the 16S rRNA amplicons was conducted using 250bp paired-end 'V4' chemistry with dual index primers (Kozich et al., 2013) .
QUANTIFICATION AND STATISTICAL ANALYSIS
Pre-processing and Community Characterization of 16S rRNA Sequence Data Sequence pre-processing followed methods previously described (Hannigan et al., 2014) , but modified by subsampling at 5000 sequences per sample for murine samples, and at 1000 sequences per sample for human samples. QIIME 1.8.0 (Caporaso et al., 2010) was used for initial stages of sequence analysis. Sequences were clustered into OTUs (operational taxonomic units, a proxy for 'species') using UCLUST (Edgar, 2010) at 97% sequence similarity. Bacterial diversity was calculated using the following alpha diversity indices: Shannon diversity index and the number of observed OTUs. Relative abundance of bacteria was calculated based on taxonomic classification of sequences using the RDP classifier (Wang et al., 2007) at a confidence threshold of 0.8. Microbiota data was analyzed with the R statistical software environment (https://www.r-project.org/). Statistical significance was determined using twosample Wilcoxon tests and corrected for multiple comparisons by FDR where appropriate. Dirichlet multinomial mixture modeling was performed using the R package Dirichlet Multinomial and calculated as previously reported (Loesche et al., 2017) .
Sample Sizes n represents the number of patients, mice, or swabs collected from each mouse as described in legends of each figure.
Statistical Analysis
Results represent means ± SEM. Data were analyzed using Prism 7.0 (GraphPad Software, San Diego, CA). Statistical significance was determined by one-way ANOVA when comparing more than two groups and by an unpaired two-tailed Student's t test to compare means of lesion sizes, parasite burdens, and cytokine production from different groups of mice. Variances were equal between experimental groups. Statistically significant differences were defined as * when p values were < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001.
DATA AND SOFTWARE AVAILABILITY
The accession number for the 16S rRNA gene sequence data reported in this paper is SRA: PRJNA389688.
